Diagnostic yield and limitations of whole-genome sequencing for hereditary cerebellar ataxia

Less than half of the individuals with hereditary cerebellar ataxia receives a genetic diagnosis. Repeat expansions account for disproportionate number of hereditary cerebellar ataxia and have genetically heterogeneous causes. These genetic loci include <i>ATXN1</i>, <i>ATXN2</i>, <i>ATXN3</i>, <i>CACNA1A</i>, <i>ATXN7</i>, <i>ATXN8OS</i>, <i>ATXN10</i>, <i>PPP2R2B, TBP</i>, <i>ATN1</i>, <i>FMR1, BEAN1, NOP56, GLS, THAP11, GAA-FGF14, ZFHX3, FXN</i> and <i>RFC1.</i> This study aims to assess the yield of short-read whole genome sequencing in the molecular diagnosis of hereditary cerebellar ataxia. We recruited 380 patients (351 probands) from a national ataxia centre in United Kingdom. They underwent short-read whole genome sequencing as a part of the 100 000 Genomes Project. Bioinformatic pipeline of whole genome sequencing include variant prioritization in selected virtual gene panels, customized analysis with a focus on repeat expansions, structural variants and recently reported hereditary cerebellar ataxia genes. All potential genetic variants were reviewed in a multidisciplinary team, and further confirmation tests were performed as appropriate. Whole genome sequencing identified causative variants in 115 (33%) out of 351 probands. We established 46 distinct presumptive molecular diagnoses with the most frequent being <i>SPG7</i> (<i>n</i> = 22)<i>, RFC1</i> (<i>n</i> = 20) and <i>CACNA1A</i> (<i>n</i> = 10). However, it failed to detect any probands with novel ataxia gene <i>GAA-FGF14</i>, which was subsequently identified on polymerase chain reaction screening in 10 unsolved probands. In conclusion, whole genome sequencing is a useful diagnostic test in hereditary cerebellar ataxia patients and can be used to detect repeat expansions, structural and mitochondrial variants. However, identification of complex structural variants and sizing of large repeat expansions remains a challenge and require alternative molecular testing techniques.

Authors

Institutions

Publication Details

Journal
Brain Communications
Published
2025-01-01
DOI
https://doi.org/10.1093/braincomms/fcaf188
Citations
3
Primary Topic
Genetic Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
2.73

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Diagnostic yield and limitations of whole-genome sequencing for hereditary cerebellar ataxia

Bernard Brais, Stephan Züchner, Matt C. Danzi, David Pellerin et al.
3 citations
Brain Communications
Genetic Neurodegenerative Diseases
2.73
article

Diagnostic yield and limitations of whole-genome sequencing for hereditary cerebellar ataxia

Bernard Brais, Stephan Züchner, Matt C. Danzi, David Pellerin, Roisin Sullivan, Michael Parkinson, Jana Vandrovcová, Paola Giunti, Nicholas William Wood, Henry Houlden, Wai Yan Yau, Marie‐Josée Dicaire, Emer O’Connor
article en
3 citations

Abstract

Less than half of the individuals with hereditary cerebellar ataxia receives a genetic diagnosis. Repeat expansions account for disproportionate number of hereditary cerebellar ataxia and have genetically heterogeneous causes. These genetic loci include <i>ATXN1</i>, <i>ATXN2</i>, <i>ATXN3</i>, <i>CACNA1A</i>, <i>ATXN7</i>, <i>ATXN8OS</i>, <i>ATXN10</i>, <i>PPP2R2B, TBP</i>, <i>ATN1</i>, <i>FMR1, BEAN1, NOP56, GLS, THAP11, GAA-FGF14, ZFHX3, FXN</i> and <i>RFC1.</i> This study aims to assess the yield of short-read whole genome sequencing in the molecular diagnosis of hereditary cerebellar ataxia. We recruited 380 patients (351 probands) from a national ataxia centre in United Kingdom. They underwent short-read whole genome sequencing as a part of the 100 000 Genomes Project. Bioinformatic pipeline of whole genome sequencing include variant prioritization in selected virtual gene panels, customized analysis with a focus on repeat expansions, structural variants and recently reported hereditary cerebellar ataxia genes. All potential genetic variants were reviewed in a multidisciplinary team, and further confirmation tests were performed as appropriate. Whole genome sequencing identified causative variants in 115 (33%) out of 351 probands. We established 46 distinct presumptive molecular diagnoses with the most frequent being <i>SPG7</i> (<i>n</i> = 22)<i>, RFC1</i> (<i>n</i> = 20) and <i>CACNA1A</i> (<i>n</i> = 10). However, it failed to detect any probands with novel ataxia gene <i>GAA-FGF14</i>, which was subsequently identified on polymerase chain reaction screening in 10 unsolved probands. In conclusion, whole genome sequencing is a useful diagnostic test in hereditary cerebellar ataxia patients and can be used to detect repeat expansions, structural and mitochondrial variants. However, identification of complex structural variants and sizing of large repeat expansions remains a challenge and require alternative molecular testing techniques.

Brain CommunicationsVol. 7(3)
Montreal Neurological Institute and Hospital (CA), University College London Hospitals NHS Foundation Trust (GB), University of Miami (US), The University of Western Australia (AU), Dr. John T. Macdonald Foundation (US), Perron Institute for Neurological and Translational Science (AU), National Hospital for Neurology and Neurosurgery (GB), University College London (GB), McGill University (CA)
Royal Australasian College of Physicians, Department of Health, Government of Western Australia, Canadian Institutes of Health Research
Good health and well-being
Openalex Percentile: Top 10%
Genetic Neurodegenerative Diseases
2.73
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.